Hunter Land

Hunter Land

Director of Cannabinoid Research at Canopy Growth Corporation

Hunter Land, director of cannabinoid research at Canopy Growth Corporation, has devoted his career to researching cannabis-derived medicines and their application across a variety of conditions, leading the clinical development of the first FDA-approved CBD medication, Epidolex.

Follow Hunter Land on Social


7 Surprising Facts You Didn't Know About CBD

A scientist sheds some new light on the often misunderstood cannabinoid.

Risk Versus Reality: Here's What The Current Research On CBD Tells Us

When it comes to CBD, perhaps the greatest consumer health risk is the lack of a sensible, science-backed regulatory framework.

More Authors You Might Like